Prot# A4001026: A Mltcntr, Rndmzd, Dbl-Blind, Comparative Trial Of a Novel CCR5 Antagonist, UK-427,857, in Combination w/Zidovudine/Lamivudine v. Efavirenz in Combination w/Zidovudine/Lamivudine for the Treatment of Antiretroviral-Naïve HIV-1 Infected Sbj

Project: Research project

Project Details

StatusFinished
Effective start/end date6/6/05 → 8/8/07

Funding

  • Quintiles, Inc. (A4001026)
  • Pfizer Inc. (A4001026)